Medicine
Pitocin 10 IU/mL injection
Pitocin 10 IU/mL injection is a prescription medicine containing Oxytocin for intravenous use, marketed by Par Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Oxytocin
- Brand
- Pitocin
- Strength
- 10 IU/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 vials, 6 vials and 3 more
- Marketing authorisation holder
- Par Health
- Manufacturer
- Par Health
- Origin register
- US FDA, United States
- Storage
- Store between 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01BB02 Oxytocin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 February 2008
- Identifiers
- RxCUI 207315, 238013, 1791721 +1DailyMed set ID 6e5a66fc-e507-497c-b5ce-44a8c95898ad, dddcdcc3-cd4d-4573-98ac-9468bea23a8b, 6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1 +1NDC 42023-116, 42023-130Application NDA018261
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 10 mL in 1 vial | 42023-116-02 | Par Health | 1 February 2008 |
| 25 vial in 1 tray / 1 mL in 1 vial | 42023-116-25 | Par Health | 1 February 2008 |
| 25 vial in 1 carton / 10 mL in 1 vial | 42023-116-73 | Par Health | 22 December 2023 |
| 25 vial in 1 carton / 1 mL in 1 vial | 42023-116-83 | Par Health | 22 December 2023 |
| 25 vial in 1 carton / 10 mL in 1 vial | 42023-116-93 | Par Health | 6 May 2024 |
| 6 vial in 1 carton / 50 mL in 1 vial | 42023-130-06 | Par Health | 1 May 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 April 1980 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oxytocin
Clinical summary
Oxytocin is an oxytocic indicated for the medical rather than the elective induction of labor, among other approved uses. It is available as injection for intravenous and intramuscular use. MedsAcross supplies Oxytocin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxytocinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Oxytocin prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Pitocin 10 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.